Home/Filings/4/0001567619-19-015049
4//SEC Filing

Boucher Brent J. 4

Accession 0001567619-19-015049

CIK 0001275187other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 9:36 PM ET

Size

7.2 KB

Accession

0001567619-19-015049

Insider Transaction Report

Form 4
Period: 2019-07-17
Boucher Brent J.
SVP and GM of Oncology
Transactions
  • Award

    Common Stock

    2019-07-17+3,22616,769 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-07-17+10,79010,790 total
    Exercise: $21.54From: 2020-07-17Exp: 2029-07-17Common Stock (10,790 underlying)
Footnotes (2)
  • [F1]This acquisition of 3,226 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 3,226 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023.
  • [F2]These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023.

Documents

1 file

Issuer

ANGIODYNAMICS INC

CIK 0001275187

Entity typeother

Related Parties

1
  • filerCIK 0001766229

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 9:36 PM ET
Size
7.2 KB